期刊文献+

肺癌逃逸机制研究进展 被引量:2

肺癌逃逸机制研究进展
原文传递
导出
摘要 自20世纪80年代起,肺癌已成为全球范围内发病率最高的癌症,且发病率正逐年上升,据2011年美国癌症学会统计数据,肺癌的5年总生存率仅为16%,表明肺癌在发生发展及对抗现有治疗模式上有着各种各样的逃逸机制。了解肿瘤逃逸机制找出对策,在今后肿瘤防治中可能会产生较大的突破,本文就肺癌的逃逸机制包括免疫抑制、抗凋亡及耐药三方面做一综述。
出处 《中国肿瘤临床与康复》 2013年第4期414-416,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 肺肿瘤 免疫抑制 凋亡 耐药 Lung neoplasms Immunosuppression Apoptosis Drug fast
  • 相关文献

参考文献17

  • 1Kim JI,Lakshmikanthan V,Frilot N,et al.Prostaglandin E2promotes lung cancer cell migration via EP4-β/Arrestin1-c-Srcsignalsome[J].Molecular Cancer Research,2010,8:569-577.
  • 2Kim TK,Mo EK,Yoo CG,et al.Alteration of cell growth andmorphology by over expression of transforming growth factorβtype II receptor in human lung adenocarcinoma cells[J].LungCancer,2001,31:181-191.
  • 3Di Bari MG,Lutsiak ME,Takai S,et al.TGF-beta modulatesthe functionality of tumor-infiltrating CD+8♂T cells through effects on TCR signaling and Spred1expression[J].Cancer Im-munol Immunother,2009,58:1809-1818.
  • 4刘俊才,王丽萍,张岚,王玉萍,李明君.CD4^+CD25%+FoxP3^+调节性T细胞在肺癌患者体内检测及其意义[J].中国实用医刊,2009,36(8):3-5. 被引量:7
  • 5Granville CA,Memmott RM,Balogh A.A central role for Foxp3+regulatory T cells in K-Ras-driven lung tumorigenesis[J].Plos ONE,2009,4:5061.
  • 6Brandau S,Trellakis S,Bruderek K,et al.Myeloid-derived sup-pressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties[J].Journal of Leukocyte Biology,2011,89:311-317.
  • 7Baba T,Hanagiri T,Ichiki Y,et al.Lack and restoration of sensitivity of lung cancer cells to cellular attack with special ref-erence to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B[J].Cancer Science,2007,98:1795-1802.
  • 8Kikuchi E,Yamazaki K,Torigoe T,et al.HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer[J].Cancer Science,2007,98:1424-1430.
  • 9Joseph B,Lewensohn R,Zhivotovsky B.Role of apoptosis in the response of lung carcinomas to anti-cancer treatment[J].Annals of the New York Academy of Sciences,2000,926:204-216.
  • 10Monica F,Caterina P,Antonio M,et al.Survivin gene expres-sion in early-stage non-small cell lung cnacer[J].Pathology,2003,200:620-626.

二级参考文献10

  • 1孙建国,廖荣霞,陈正堂,王志新,张青,伍伟玲.一种新的凋亡抑制蛋白Livin在非小细胞肺癌组织中的表达[J].重庆医学,2004,33(7):982-984. 被引量:47
  • 2Nnehmias B,Ashhab Y,Ben Yehuda D. The Inhibitor of Apoptosis protein family(lAPs) :an emerging therapeutic targetin cancer[J]. Semin Cancer Biol,2004,14(1) :231- 243.
  • 3Xiang Y, Yao H, Wang S,et al. Prognostic value of Survivin and Livin in nasopharyngcal carcinoma [J]. Laryngoscope,2006,116(1):126 -130.
  • 4Yagihashi A,Asanuma K,Tsuji N,et al. Detection of anti-Livin antibody in gaslrointestinal cancer patients [J]. Clin Chem,2003,10(49):1206-1208.
  • 5Tanabe H,Yagihashi A,Tsuji N,et al. Expression of Survivin mRNA and Livin mRNA in non-small-cell lung cancer[J]. Lung Cancer,2004,46(3):299- 304.
  • 6Choi J, Hwang YK, Sung KW, et al. Expression of Livin, an anti apoptotic protein, is an independent favorable prognostic factor in child acute lymphoblastic leukemia[J]. Blood,Z007,109(2):471-477.
  • 7Yagihashi A, Asanuma K, Kobayashi D. Detection of auto antibodies to Livin and Survivin in sera from lung cancer patients[J]. Lung Cancer, 2005,48(2):217-221.
  • 8刘俊华,吴纪祥,刘益飞,张裕东,张宏.Livin在非小细胞肺癌中的表达及临床意义[J].现代肿瘤医学,2010,18(2):247-249. 被引量:9
  • 9戴舒玥.如何借助观测指标设计探究实验[J].生物学教学,2018,43(5):39-40. 被引量:2
  • 10王莉.胰岛素休克的实验动物选择研究[J].教育教学论坛,2020(33):145-146. 被引量:2

共引文献13

同被引文献34

  • 1曹子昂.2014第一版NCCN小细胞肺癌治疗指南解读[J].中国医学前沿杂志(电子版),2013,5(12):79-81. 被引量:26
  • 2Ballen KK,Colvin G,Dey BR,et al.Cellular immunotherapy for re-fractory cancer novel therapeutic strategies[J]. Exp Hematology,2005,33(12):1427-1435.
  • 3Yu JB,Decker RH,Detterbeck FC,et al.Surveillance epidemiology and end results evaluation of the role of surgery for stageⅠ small cell lung cancer [J]. J Thorac Oncol,2010,5(2):215-219.
  • 4Niu Q,Wang W,Li Y,et al.Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancie[J].Int Immunop harmacol,2011,11(4):449-456.
  • 5Hao Jiang,Peng?Jun Zhao,Dan Su,Jianguo Feng,Sheng?Lin Ma.??Paris saponin I induces apoptosis via increasing the Bax/Bcl?2 ratioand caspase?3 expression in gefitinib?resistant non?small cell lung cancer in vitroand in vivo(J)Molecular Medicine Reports . 2014 (6)
  • 6Soumya Basu,Avishek Ganguly,Paramita Chakraborty,Rupashree Sen,Kaushik Banerjee,Mitali Chatterjee,Thomas Efferth,Soumitra Kumar Choudhuri.??Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff’s base to overcome MDR in cancer(J)Biochimie . 2011 (1)
  • 7C. T. Hellwig,E. Passante,M. Rehm.??The Molecular Machinery Regulating Apoptosis Signal Transduction and its Implication in Human Physiology and Pathophysiologies(J)Current Molecular Medicine . 2011 (1)
  • 8MV Fiandalo,N Kyprianou.Caspase control: protagonists of cancer cell apoptosis. Experimental Oncology . 2012
  • 9Tsai JR,Liu PL,Chen YH,et al.Ginkgo biloba extract decreases non-small cell lung cancer cell migration by downregulating metastasis-associated factor heat-shock protein 27. PLo S ONE . 2014
  • 10Qin S,Yang C,Wang X,et al.Overexpression of smac promotes cisplatin-induced apoptosis by activating caspase-3and caspase-9in lung cancer A549cells. Cancer Biotherapy and Radiopharmaceuticals . 2013

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部